SG47557A1 - Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents - Google Patents

Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents

Info

Publication number
SG47557A1
SG47557A1 SG1996002819A SG1996002819A SG47557A1 SG 47557 A1 SG47557 A1 SG 47557A1 SG 1996002819 A SG1996002819 A SG 1996002819A SG 1996002819 A SG1996002819 A SG 1996002819A SG 47557 A1 SG47557 A1 SG 47557A1
Authority
SG
Singapore
Prior art keywords
beta
aminocycloalkanobenzodioxoles
adrenergic agents
selective adrenergic
selective
Prior art date
Application number
SG1996002819A
Other languages
English (en)
Inventor
Jonathan David Bloom
Minu Dhanjisha Dutia
Gary Edward Walker
Gary Harold Birnberg
Joseph William Epstein
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG47557A1 publication Critical patent/SG47557A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SG1996002819A 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents SG47557A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1097393A 1993-01-29 1993-01-29

Publications (1)

Publication Number Publication Date
SG47557A1 true SG47557A1 (en) 1998-04-17

Family

ID=21748304

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002819A SG47557A1 (en) 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents

Country Status (10)

Country Link
US (2) US5510376A (de)
EP (1) EP0608568B1 (de)
JP (1) JPH072831A (de)
KR (1) KR940018376A (de)
AT (1) ATE163930T1 (de)
CA (1) CA2114359A1 (de)
DE (1) DE69317399T2 (de)
DK (1) DK0608568T3 (de)
ES (1) ES2115003T3 (de)
SG (1) SG47557A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
EP0825189B1 (de) * 1995-05-12 2002-01-02 Nisshin Pharma Inc. 1,4-benzodioxin-derivate
EP0801060A1 (de) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclische Beta-3 adrenergische Angonisten
EP1070046A1 (de) * 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolaminderivate
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
JP5535931B2 (ja) * 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles

Also Published As

Publication number Publication date
KR940018376A (ko) 1994-08-16
US5594027A (en) 1997-01-14
US5510376A (en) 1996-04-23
DK0608568T3 (da) 1998-09-28
CA2114359A1 (en) 1994-07-30
ATE163930T1 (de) 1998-03-15
EP0608568B1 (de) 1998-03-11
DE69317399T2 (de) 1998-07-02
JPH072831A (ja) 1995-01-06
ES2115003T3 (es) 1998-06-16
EP0608568A1 (de) 1994-08-03
DE69317399D1 (de) 1998-04-16

Similar Documents

Publication Publication Date Title
TW269678B (de)
SG47559A1 (en) 7-(substituted)-9-[(substituted glycl) amido]-6-demethyl-6-deoxytetracyclines
TW218869B (de)
IL106677A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
EP0984778A4 (de) Liganden des neuropeptids y
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
EP0698606A4 (de)
ES2115003T3 (es) Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.
IL133279A0 (en) Carboxamides useful as 5-ht1f agonists
ES2094136T3 (es) Intermediarios quirales de 1,5-diyodo-2-metoxi o benciloxi.
GR3020351T3 (en) Propoxybenzene derivatives and process for preparing the same
TW278071B (de)
EP0990635A4 (de) Hydroxycyclopentanone
EP0841327A4 (de) Triazole als fungizide mittel.
TW231256B (de)
ATE72445T1 (de) 4'-epi-4'-aminoanthracycline.
DE69022560D1 (de) N,N'-hydrocarbylen-bis-(N-hals)-substituierte Amidhydrazide.
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
MX9603273A (es) Tetrahidropirimidinas artropodicidas.
TH15423A (th) อนุพันธ์ไธอะโซโลพิริมิดีน
UA16247A1 (uk) N-(3-ХЛОРО-1,4-HАФТОХІHОHІЛ-2)-2-Д, alРha-АСПАРАГІHОВУ КИСЛОТА, ЩО ПРОЯВЛЯЄ КАРДІОСТИМУЛЮЮЧІ ВЛАСТИВОСТІ